Back to Search
Start Over
S302: LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF THE ADVANCE+ STUDY.
- Source :
- HemaSphere; 2023 Supplement 3, Vol. 7, pe02996d3-e02996d3, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 169965852
- Full Text :
- https://doi.org/10.1097/01.HS9.0000968120.02996.d3